Director's Welcome

Welcome to the Division of Gynecologic Oncology at the University of Cincinnati. As physicians dedicated to improving the care of women with gynecologic cancer, we appreciate your interest and the ability to let you know more about what we do.

Each year more than 80,000 women in the United States are diagnosed with new cancers of the female reproductive organs. These include some that many people recognize, such as ovarian, cervical and endometrial cancers, and some that are less common, such as vaginal and vulvar cancers, gynecologic sarcomas and gestational trophoblastic disease.

Gynecologic oncologists are physicians dedicated to treating women with these conditions. We acquire our initial skills in the complex surgical and medical management of these cancers through three to four additional years of training after obstetrics and gynecology residency, and spend a lifetime honing this expertise.

The goal for all gynecologic oncologists is the same: to help women with gynecologic cancer each year live longer, with fewer side effects from treatment and a better chance to beat their cancer for good.

Improving gynecologic cancer care has many facets, and at the University of Cincinnati, we are proud of the role we play in advancing this standard. Clinical trials are a way to give patients access to new techniques for early diagnosis and new therapies for cancer treatment, in many cases before these therapies are otherwise available.

The clinical trials administered through the National Cancer Institute’s NRG Oncology Group (formerly GOG) have led to the most important advances in gynecologic cancer therapy for the last 40 years, and as a primary NRG Oncology member institution, we take an active role in designing and monitoring these trials. We actively partner with our colleagues in the University of Cincinnati Cancer Institute to advance the care of all cancer patients in the Tristate region.

This is an exciting time for cancer therapy. A better understanding of cancer genetics, and a host of new targeted treatments with fewer side effects, allows more opportunities to individualize treatment for each woman with gynecologic cancer.

Innovations in laparoscopic and robotic surgical techniques allow our patients to recover from surgery more quickly, and allow many women diagnosed with gynecologic cancer early in life to retain their fertility.

For more complex surgical problems, our team of surgeons, anesthesiologists and intensivists allow us not only to remove tumors that were previously considered unresectable, but to get patients healed, home and back to their normal activities.

We are grateful for the role we play in resident and medical student education, and for the role we play in raising awareness for gynecologic cancer research. Our specialty interfaces with many medical disciplines, and we are fortunate to work closely with our Department members in reproductive endocrinology, urogynecology, pediatric and general gynecology, and women’s health.  

We look forward working with you, whether as a patient, family member, colleague or interested community member. Please contact us at 513-584-6373 if we can be of service.

Sincerely,

Amanda Jackson, MD
Division Director